Golden State Equity Partners Astrazeneca PLC Transaction History
Golden State Equity Partners
- $510 Million
- Q4 2024
A detailed history of Golden State Equity Partners transactions in Astrazeneca PLC stock. As of the latest transaction made, Golden State Equity Partners holds 5,809 shares of AZN stock, worth $422,081. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,809
Previous 1,235
370.36%
Holding current value
$422,081
Previous $96,000
295.83%
% of portfolio
0.07%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,352Shares Held
478MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.57 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.98 Billion2.12% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.71 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.68 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.39 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $225B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...